Ticker Details
Tango Therapeutics, Inc.
IPO Date:	September 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.64B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 3.78%
Avg Daily Range (30 D):	$0.35 | 3.02%
Avg Daily Range (90 D):	$0.33 | 3.36%

Institutional Daily Volume
Avg Daily Volume:	.92M
Avg Daily Volume (30 D):	2.62M
Avg Daily Volume (90 D):	2.81M

Trade Size
Avg Trade Size (Sh.):	112
Avg Trade Size (Sh.) (30 D):	102
Avg Trade Size (Sh.) (90 D):	105

Institutional Trades
Total Institutional Trades:	985
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$1.89M
Avg Institutional Trade (90 D):	$2.04M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.83M
Avg Closing Trade (30 D):	$2.3M
Avg Closing Trade (90 D):	$2.75M
Avg Closing Volume:	228.17K

News

Jan 5, 2026 @ 12:00 PM Tango Therapeutics Appoints Sung Lee to Board of D... Source: Na

Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D.

Aug 6, 2025 @ 12:25 AM Tango (TNGX) Q2 Revenue Drops 52% Source: Na

Jun 27, 2025 @ 11:00 AM Tango Therapeutics Announces First Patient Dosed i... Source: Tango Therapeutics

May 27, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 46th Annu... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.91	$.14	$-.35
Diluted EPS	$-.91	$.13	$-.35
Revenue	$66.5M	$53.81M	$3.18M
Gross Profit
Net Income / Loss	$-100.52M	$15.88M	$-38.85M
Operating Income / Loss	$-110.34M	$14.07M	$-40.97M
Cost of Revenue
Net Cash Flow	$5.19M	$19.07M	$-19.16M
PE Ratio